Andrew B. Lassman, MD Specialties: Neurology, Cancer Care, Neuro-Oncology



Address
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
- AETNA
- Affinity Health Plan
- AgeWell
- Amida Care
- CIGNA
- Emblem/GHI
- Emblem/Hip
- Empire Blue Cross Blue Shield Healthplus
- Empire Blue Cross/Blue Shield
- Fidelis Care
- Healthfirst
- Local 1199
- Magnacare (National)
- Medicare
- Multiplan
- MVP Health Care
- Oxford Health Plans
- Quality Health Management
- RiverSpring
- UnitedHealthcare
- VNSNY CHOICE
- WellCare
About Andrew B. Lassman, MD
Andrew B. Lassman, MD, is a Professor of Neurology and Associate Dean of Clinical Trials at the Columbia University Vagelos College of Physicians and Surgeons. Dr. Lassman also serves as Chief of the Department of Neurology Division of Neuro-Oncology and Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center. As a clinician-scientist, Dr. Lassman focuses both his research and clinical efforts on improving the understanding and treatment of brain tumors.Dr. Lassman has particular expertise in translational clinical trials for brain tumors, with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. His contributions to the field of Neuro-Oncology have been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry, as part of a combined four-year program at Yale University. He attained his MD from Columbia University College of Physicians and Surgeons and completed Neurology residency at the Neurological Institute of New York, at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he joined the faculty and served as fellowship director, until his return to NewYork-Presbyterian/Columbia University Irving Medical Center.
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
Expertise
Acoustic Neuroma
Anaplastic Astrocytoma
Astrocytoma
Brain Cancer
Brain Metastases
Brain Stem Glioma
Brain Tumor
Carcinomatous meningitis
Chordoma
Choroid Plexus Carcinoma
Choroid Plexus Papilloma
Ependymoma
Glioblastoma
Glioblastoma Multiforme
Gliomas
Hemangioblastoma
Leptomeningeal metastases
Medulloblastoma
Meningioma
Metastatic Cancer
Mixed Glioma
Neurofibromatosis
Oligoastrocytoma
Oligodendroglioma
Second Opinion
Spinal Cord Tumor
Spinal Tumors
Education
- Fellowship: Memorial Sloan-Kettering Cancer Center, New York, NY
- Internship: Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital Program, New York, NY
- Medical School: Columbia University College of Physicians and Surgeons
- Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY
Board Certifications
- Neurology
Awards
- Clinician of the Year, Neurology, Columbia University Irving Medical Center, 2022
- Nobility in Science Award, Oligo Nation, 2021
- Fellow of the American Academy of Neurology (FAAN), 2020
- Adult Clinical Research Abstract Award, Society for Neuro-Oncology, 2019For excellence in adult clinical research (1 recipient annually)
- Americas Top Doctors for Cancer, Castle Connolly, 2016-present
- Top Doctors, New York Magazine, 2013-present
- Gary Lichtenstein Humanitarian Award, Voices Against Brain Cancer, 2012
- John Harris Associate Professorship of Neurology, 2012-presentColumbia University in the City of New York
- Boyer Clinical Research Award, Memorial Sloan Kettering Cancer Center, 2010For outstanding research accomplishments under the age of 40(1 recipient annually)
- Preuss Award in Neuro-Oncology, American Academy of Neurology, 2008For demonstrating exceptional commitment and potential in clinical neuro-oncology research and to recognize important and relevant clinical advances in the discipline(1 recipient annually)
- Neurology Resident Teaching Award, 2004-05, 10-11Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
- Chief Fellow, Neuro-Oncology, Memorial Sloan Kettering Cancer Center, 2002-03(1 annually)
- Phi Beta Kappa, Yale University, 1992